The U.S. Supreme Court has declined to hear petitions from six major drugmakers challenging the Medicare Drug Price Negotiation Program, leaving in place lower court rulings that upheld the program ...

John writes about the politics of health care, and he is the author of the twice-weekly D.C. Diagnosis newsletter. You can reach John on Signal at John_Wilkerson.07. WASHINGTON — The Trump ...

Real estate expert shares when sellers are most likely to accept deep discounts and the key signs buyers can use to negotiate ...

AARP and other consumer groups are hailing the Supreme Court’s decision that continues the cost-cutting, money-saving ...

In the U.S., many top brand-name drugs continue to get more expensive with age, while the same medicines often get cheaper in peer countries, according to an AARP Public Policy Institute ...

Despite continued talk of a seller’s market in many parts of the country, there may be more room for negotiating price than you might think. It’s not as simple as asking for a better deal, though. To ...

The Supreme Court has rejected appeals from pharmaceutical companies that object to negotiating Medicare drug prices with the ...

Negotiating a home price is a high-stakes process that requires preparation, strategy and data-driven decisions. It’s important to prepare carefully so that you don’t underbid while selling or overbid ...

Advocates are praising a recent move by the Supreme Court, calling it a victory for millions of older Americans who rely on ...

The third round of the Medicare Drug Price Negotiation Program is moving forward with full manufacturer participation. The program, created under the Inflation Reduction Act, allows CMS to directly ...

The One Big Beautiful Bill Act removed a number of orphan drugs from being subject to price negotiations, and this could cost the Medicare program $8.8 billion over the course of about 10 years. That ...